All posts by Saaly Temirkanov
Understand how growing law firms like the Switalskis Group are unlocking sustainable cashflow fast, to take advantage of acquisition and investment opportunities that set them apart from the competition. (more…)
The headliners in the recent Court of Appeal Potter judgment (a win for PPI2 claimants and the Plevin litigators and CMCs representing them) are powerful and many. The judgment is also expected to impact other credit product claims (more…)
The legal media is rife with acquisition news and ‘talks’ between businesses this year. Large regional law firms – and others – are on the hunt. If you’re considering making your acquisition move, don’t let a fear of financing your purchase put you off. (more…)
Increasing pressure from the FCA and the news that large CMCs will not renew their regulator licence will impact the Plevin litigation market in the coming months. CMCs will have to act fast to instruct law firms before the inevitable court backlog starts.
On the back of a successful year, thanks to growing demand for our litigation funding products, we are recruiting for three new roles to expand our auditing, investment book and IT departments. (more…)
The most reputable medical agencies offer a life-line to clinical negligence litigation firms through extended credit lines for cases but what happens when this extended credit expires and fees are due? (more…)
Potter has the potential to impact on all types of credit claims, not just PPI, when the case lands in the Court of Appeal in January 2021 – but what does it mean for law firms handling Plevin litigation now? (more…)
We have collaborated with the Alliance of Claims Companies (ACC) to create a sustainably funded and resourced ‘Plevin Panel’ to offer a powerful solution for CMCs pursuing Plevin through litigation. (more…)
Headlines of law firm redundancies are rife and are set to dominate when the Job Protection Scheme ends. Funding is also big news as firms look beyond CBILS Loans to access cash, quickly. (more…)
The consumer press has this week championed successful case studies covering new settlements for PPI consumers, achieved by law firms that are leading the way in Plevin litigation. (more…)
Our third Plevin Forum was held in July 2020 and was the largest event we’ve held to date. The Forums give claimant firms the opportunity to share and discuss the latest market intelligence on Plevin litigation.
It’s almost a year since the FCA’s much publicised PPI deadline of August 29th which was intended to bring an end to PPI misselling claims. (more…)
COVID-19 has presented significant challenges in the way we all must conduct business, and the practice of law is no exception. (more…)
Covid-19 is impacting businesses across the globe. We wish to assure you that SpectraLegal remains open for business and committed to maintaining the unparalleled standard of service to which our clients are accustomed.
To our Friends, Partners and Investors,
These are unprecedented times indeed, Spectralegal sincerely hope you, your colleagues and family are safe and well.
SpectraLegal are launching 2 new products which provide solutions to the common challenges faced by all litigation practices.
The SpectraLegal Finance Group is very pleased to announce it has entered into a transaction with Waterfall Asset Management, LLC to provide £100 million in finance for its European legal finance business (more…)
Thanks to a consultation curve ball over the way the Personal Injury Discount Rate is set, claimant practitioners (who, only weeks ago were celebrating the new rate of -0.75%) are increasingly finding themselves in a settlement limbo that has consequences for both the client and the firm: a lack of cash flow.
We recently chaired a roundtable debate bringing together some of the leading lights in the industry to discuss the various challenges that firms currently face and what firms can do to help build towards a sustainable future.
Show your practices the same care you devote to your clients, warns Matthew Gwynne
Matthew Gwynne: amazed how often solicitors overlook these dangers.
Setting and keeping costs budgets are a good discipline, even where this isn’t mandatory and however unclear the rules may be, says Matthew Gwynne.
Our Business Development Director, Matthew Gwynne, discusses the recent NHSLA report.